This grant funds international projects in low- and middle-income countries to strengthen detection, surveillance, and prevention of antimicrobial resistance and infections through research and implementation activities.
Funder: Centers for Disease Control - NCEZID
Due Dates (Anticipated): May 2027 (Full application deadline, projected)
Funding Amounts: Estimated total program funding: $60,000,000; ~30 awards anticipated; award size varies
Summary: Supports international implementation and targeted research to address antimicrobial resistance, healthcare-associated infections, and emerging infectious disease threats, especially in low- and middle-income countries.
This opportunity is a forecasted cooperative agreement from the Centers for Disease Control and Prevention’s National Center for Emerging and Zoonotic Infectious Diseases (NCEZID). The program aims to link non-research implementation with targeted research that advances CDC’s mission to combat antimicrobial resistance (AR) across bacterial and fungal pathogens, healthcare-associated infections (HAIs), and emerging infectious disease threats, including viral pathogens. The focus is on strengthening detection, surveillance, prevention, and response systems in low- and middle-income countries to reduce illness and death, stop the spread of AR, protect healthcare workers and patients, and lower costs through robust infection prevention and control (IPC) and antimicrobial stewardship. The initiative builds on CDC’s Global AR Laboratory and Response Network, HAI surveillance and prevention networks, and related programs.